Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients.
Mir
Olivier
O
Dessard-Diana
Bernadette
B
Louet
Agnès Lillo-Le
AL
Loulergue
Pierre
P
Viard
Jean-Paul
JP
Langlois
Anne
A
Durdux
Catherine
C
Le Beller
Christine
C
D000328:Adult; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D000077143:Docetaxel; D004347:Drug Interactions; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced; D009503:Neutropenia / Q000139:chemically induced*; D019438:Ritonavir / Q000009:adverse effects* / Q000493:pharmacokinetics; D003294:Seizures, Febrile / Q000139:chemically induced; D043823:Taxoids / Q000493:pharmacokinetics*
D000970:Antineoplastic Agents; D017320:HIV Protease Inhibitors; D043823:Taxoids; D000077143:Docetaxel; D019438:Ritonavir